Your browser doesn't support javascript.
Does delaying curative surgery for colorectal cancer influence long-term disease-free survival? A cohort study.
Garcia-Botello, Stephanie; Martín-Arevalo, J; Cozar-Lozano, C; Benitez-Riesco, A; Moro-Valdezate, D; Pla-Martí, V; Espí-Macías, A.
  • Garcia-Botello S; Colorectal Surgery Unit, Biomedical Research Institute INCLIVA, Hospital Clinico Universitario, Valencia, Spain. stephanie.garcia@uv.es.
  • Martín-Arevalo J; Department of Surgery, Universidad de Valencia, Valencia, Spain. stephanie.garcia@uv.es.
  • Cozar-Lozano C; Colorectal Surgery Unit, Biomedical Research Institute INCLIVA, Hospital Clinico Universitario, Valencia, Spain.
  • Benitez-Riesco A; Colorectal Surgery Unit, Biomedical Research Institute INCLIVA, Hospital Clinico Universitario, Valencia, Spain.
  • Moro-Valdezate D; Colorectal Surgery Unit, Biomedical Research Institute INCLIVA, Hospital Clinico Universitario, Valencia, Spain.
  • Pla-Martí V; Colorectal Surgery Unit, Biomedical Research Institute INCLIVA, Hospital Clinico Universitario, Valencia, Spain.
  • Espí-Macías A; Department of Surgery, Universidad de Valencia, Valencia, Spain.
Langenbecks Arch Surg ; 406(7): 2383-2390, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1303320
ABSTRACT

BACKGROUND:

Surgical wait list time is a major problem in many health-care systems and its influence on survival is unclear. The aim of this study is to assess the impact of wait list time on long-term disease-free survival in patients scheduled for colorectal cancer resection. MATERIALS AND

METHODS:

A prospective study was carried out in patients with colorectal cancer scheduled for surgery at a tertiary care center. Wait list time was defined as the time from completion of diagnostic workup to definitive surgery and divided into 2-week intervals from 0 to 6 weeks. The outcome variables were 2-year and 5-year disease-free survival.

RESULTS:

A total of 602 patients, 364 (60.5%) male, median age 73 years (range = 71) were defined. The median wait list time was 28 days (range = 99). Two and 5-year disease-free survival rates were 521 (86.5%) and 500 (83.1%) respectively. There were no differences in 2-year or 5-year disease-free survival for the whole cohort or by tumor stage between wait list time intervals except for AJCC stage II tumors which showed a higher 5-year disease-free survival for the 2-4 and 4-6-week wait list time interval (p = 0.021).

CONCLUSIONS:

Time from diagnosis to definitive surgery up to 6 weeks is not associated with a decrease in 2-year or 5-year disease-free survival (DFS) in AJCC stage I through III colorectal cancer patients. These are important findings in the light of the COVID-19 pandemic and offer a window of opportunity for preoperative optimization and prehabilitation.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Colorectal Neoplasms / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Humans / Male Language: English Journal: Langenbecks Arch Surg Year: 2021 Document Type: Article Affiliation country: S00423-021-02251-4

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Colorectal Neoplasms / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Humans / Male Language: English Journal: Langenbecks Arch Surg Year: 2021 Document Type: Article Affiliation country: S00423-021-02251-4